Structure | Chemical Name | CAS | MF |
|
1-(2-(benzyloxy)-4-fluorophenyl)ethanone
|
106245-03-8
|
C15H13FO2
|
|
Bis(4-amino-2-chloro-3,5-diethylphenyl)methane
|
106246-33-7
|
C21H28Cl2N2
|
|
GAMMA-METHYL-L-LEUCINE
|
106247-35-2
|
C7H15NO2
|
|
1,2-dipalmitoyl glycero-3-thiophosphate
|
106249-23-4
|
C35H69O7PS
|
|
[1,3]Dioxolo[4,5-f]-1,2-benzisoxazole(9CI)
|
106253-12-7
|
C8H5NO3
|
|
[1,3]Dioxolo[4,5-g]-1,2-benzisoxazole(9CI)
|
106253-13-8
|
C8H5NO3
|
|
TRIPHENYLOLMETHANE TRIGLYCIDYL ETHER 2,6-TOLYLENE DIISOCYANATE ADDUCT
|
106253-69-4
|
C37H34N2O8
|
|
anabol
|
106254-15-3
|
|
|
C.I. Direct Blue 237
|
106254-34-6
|
|
|
Hemophan
|
106254-94-8
|
|
|
2,3,6,2',3',4',6'-hepta-O-acetylcellobiose
|
106256-88-6
|
C26H36O18
|
|
2,3,4,6-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSYL(1-4)-2,3,6-TRI-O-ACETYL-ALPHA-D-GLUCOPYRANOSYL IMIDATE
|
106256-89-7
|
C28H36Cl3NO18
|
|
5-METHYL-2-(2,4,6-TRICHLOROPHENYL)-2H-PYRAZOL-3-YLAMINE
|
106259-87-4
|
C10H8Cl3N3
|
|
1-Propen-2-ol, 1-(2-pyridinyl)-, (Z)- (9CI)
|
106259-96-5
|
C8H9NO
|
|
2-Propanone,1-(2(1H)-pyridinylidene)-,(Z)-
|
106259-97-6
|
C8H9NO
|
|
2-Propanone, 1-chloro-3-(2-pyridinyl)-
|
106260-02-0
|
C8H8ClNO
|
|
4-[4-[4-(Furo[3,2-c]pyridin-4-yl)piperazin-1-yl]butyl]-3,5-morpholinedione
|
106260-91-7
|
|
|
4-PIPERAZIN-1-YLTHIENO[3,2-C]PYRIDINE
|
106261-27-2
|
C11H13N3S
|
|
4-(4-Methylpiperazin-1-ylmethyl)benzoic acid
|
106261-48-7
|
C13H18N2O2
|
|
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
|
106261-49-8
|
C13H20Cl2N2O2
|
|
4-DIETHYLAMINOMETHYL-BENZOIC ACID HYDROCHLORIDE
|
106261-54-5
|
C12H18ClNO2
|
|
4-(4-Methylpiperazinylmethyl)benzoyl chloride dihydrochloride
|
106261-64-7
|
C13H18Cl2N2O
|
|
5-AMINO-2-ETHOXYBENZOIC ACID
|
106262-38-8
|
C9H11NO3
|
|
2-CHLORO-1-(3-CHLORO-PHENYL)-ETHANOL
|
106262-93-5
|
C8H8Cl2O
|
|
4-(2-CHLOROPHENYL)-4-OXOBUTYRIC ACID
|
106263-50-7
|
C10H9ClO3
|
|
3-OXO-3-(4-TRIFLUOROMETHYLPHENYL)PROPIONIC ACID ETHYL ESTER
|
106263-53-0
|
C12H11F3O3
|
|
Dimethyl thio-toluene diamine
|
106264-79-3
|
C9H12N2S
|
|
12-KETOSTEARIC ACID 2-AMINO-2-METHYLPROPAN-1-OL KETAL
|
106264-99-7
|
C22H43NO3
|
|
2-Bromo-2-methylbutanoyl bromide
|
106265-07-0
|
C5H8Br2O
|
|
2-bromooctanoyl bromide
|
106265-08-1
|
C8H14Br2O
|
|
3-Cyclohexene-1-carbonyl chloride, 1,4,6-trimethyl- (9CI)
|
106265-57-0
|
C10H15ClO
|
|
4-(2,4-Difluorobenzoyl)-piperidine hydrochloride
|
106266-04-0
|
C12H14ClF2NO
|
|
Risperidone
|
106266-06-2
|
C23H27FN4O2
|
|
METHYL RISPERIDONE
|
106266-08-4
|
C24H25FN4O2
|
|
Desfluoro Risperidone
|
106266-09-5
|
C23H28N4O2
|
|
6-Desfluoro-6-hydroxy Risperidone
|
106266-11-9
|
C23H28N4O3
|
|
1,3-Dioxolane-4-carbonyl chloride, 2,2-dimethyl-4-(2-propenyl)-, (S)- (9CI)
|
106268-01-3
|
C9H13ClO3
|
|
1-Behenyl-2-lauryl-sn-glycero-3-phosphocholine
|
106268-90-0
|
|
|
(2R)-(-)-GLYCIDYL 4-NITROBENZOATE
|
106268-95-5
|
C10H9NO5
|
|
(2R)-(-)-2-METHYLGLYCIDYL 4-NITROBENZOATE
|
106268-96-6
|
C11H11NO5
|
|
(2S,3S)-TRANS-3-METHYLOXIRANE-2-METHYL 4-NITROBENZOATE
|
106268-97-7
|
C11H11NO5
|
|
2,3-EPOXY-3-METHYLBUTYLESTER-4-NITROBENZOATE
|
106268-98-8
|
C12H13NO5
|
|
benzyl-(4,6-dimethyl-pyrimidin-2-yl)-amine
|
106270-42-2
|
C13H15N3
|
|
3-methoxy-4-(5-methylsulfanylpentoxy)aniline
|
106270-88-6
|
C13H21NO2S
|
|
3-Pyridineacetamide,N-methyl-(6CI,9CI)
|
106271-65-2
|
C8H10N2O
|
|
BenzeneethanaMine, 4-phenoxy-, hydrochloride
|
106272-17-7
|
C14H16ClNO
|
|
BenzenaMine, 2-[(4-Methoxyphenyl)Methoxy]-
|
106272-20-2
|
C14H15NO2
|
|
1-Naphthonitrile,6-ethoxy-3,7,8,8a-tetrahydro-8a-methyl-(6CI)
|
106272-63-3
|
C14H17NO
|
|
3-Amino-biphenyl-2-carbonitrile
|
106274-68-4
|
C13H10N2
|
|
[2-(2-MORPHOLINOETHOXY)PHENYL]METHANOL
|
106276-04-4
|
C13H19NO3
|
|
ethyl 4-(1-benzofuran-2-yl)-2,4-dioxobutanoate
|
106276-58-8
|
C14H12O5
|
|
Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl ester, reaction products with 4-[(4-aminophenyl)azo]-3-methylbenzenamine and sodium methoxide
|
106276-78-2
|
C23H20Cl4N5NaO3
|
|
Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl ester, reaction products with 2-methyl-1,3-benzenediamine and sodium methoxide
|
106276-79-3
|
C23H8Cl8N4O2
|
|
Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl ester, reaction products with p-phenylenediamine and sodium methoxide
|
106276-80-6
|
C16H16Cl4N3NaO3
|
|
demethylchlortetracycline
|
106276-91-9
|
C21H21ClN2O8
|
|
1-(2-Diethylaminoacetamidomethylphenoxy)-n-octane hydrochloride
|
106280-82-4
|
|
|
1H-Pyrrolizine-3-carboxylicacid,hexahydro-5-oxo-,cis-(9CI)
|
106281-22-5
|
C8H11NO3
|
|
1H-Pyrrolizine-3-carboxylicacid,hexahydro-5-oxo-,trans-(9CI)
|
106281-23-6
|
C8H11NO3
|
|
2-Butenoic acid, (6-oxo-1-cyclohexen-1-yl)methyl ester
|
106281-45-2
|
C11H14O3
|
|
VIRIDICACID
|
106283-19-6
|
C24H30N4O5
|
|
METHYLPYRROPORPHYRIN XXI ETHYL ESTER
|
106283-63-0
|
C34H40N4O2
|
|
SIPI 549
|
106287-81-4
|
C22H25NO4.ClH
|
|
2-(5-methoxy-2-methyl-1-phenacyl-indol-3-yl)acetic acid
|
106287-90-5
|
C20H19NO4
|
|
1-(4-Methylphenacyl)-2-methyl-5-methoxyindol-3-ylacetic acid
|
106287-91-6
|
C21H21NO4
|
|
1-(2-Cyclohexyl-2-oxoethyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid
|
106287-92-7
|
C20H25NO4
|
|
2-Methyl-7-(p-methoxybenzoyl)indol-3-ylacetic acid
|
106287-95-0
|
|
|
3-N-methylparomomycin I
|
106288-50-0
|
C24H47N5O14
|
|
Formamide, N-(1,4-dihydro-4-oxo-5-pyrimidinyl)- (9CI)
|
106289-05-8
|
C5H5N3O2
|
|
4-[4-(Decyloxy)-3-fluorophenyl]-benzoic acid
|
106291-00-3
|
C23H29FO3
|
|
3'-FLUORO-4'-METHOXYLBIPHENYL-4-CARBOXYLIC ACID
|
106291-25-2
|
C14H11FO3
|
|
4-(2-Chloro-3-hydroxyphenyl)benzoic acid
|
106291-26-3
|
C13H9FO3
|
|
METHYL 4-BROMO-3-HYDROXYBENZOATE
|
106291-80-9
|
C8H7BrO3
|
|
Alloisoleucine, 2-methyl- (9CI)
|
106292-42-6
|
C7H15NO2
|
|
1-OLEOYL-2-LINOLEOYL-RAC-GLYCEROL (CONTAINS 2% 1,3-ISOMER)
|
106292-55-1
|
C39H70O5
|
|
[R-(E)]-2-Ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine (R-EDDP)
|
106293-55-4
|
C20H23N
|
|
[S-(E)]-2-Ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine (S-EDDP)
|
106293-57-6
|
C20H23N
|
|
(2R)-5β-Amino-2α-[(3E,5E)-3,5-tridecadienyl]piperidin-4β-ol
|
106293-83-8
|
C18H34N2O
|
|
Sikokianin A
|
106293-99-6
|
C31H24O10
|
|
(2,2'-Bipyridine)bis(2-phenylpyridinato)iridium(III) Hexafluorophosphate
|
106294-60-4
|
C32H24F6IrN4P
|
|
1,4-Cyclohexadiene-1-carboxamide,3,6-dioxo-(9CI)
|
106296-27-9
|
C7H5NO3
|
|
1,3-Benzodioxole-4-carbonyl chloride, 2,2-dimethyl- (9CI)
|
106296-53-1
|
C10H9ClO3
|
|
(3-ETHOXYCARBONYL-2-OXOPROPYL)TRIPHENYLPHOSPHONIUM CHLORIDE
|
106302-03-8
|
C24H24ClO3P
|
|
TETRABUTYLAMMONIUM ETHOXIDE SOLUTION, ~4 0% IN ETHANOL
|
106303-37-1
|
C18H41NO
|
|
BOC-BETA,BETA-DIMETHYL-D-CYS(MOB)-OH
|
106306-57-4
|
C18H27NO5S
|
|
L-Arginine, N2-[1-(1-L-lysyl-L-prolyl)-L-prolyl]-
|
106306-72-3
|
C22H40N8O5
|
|
7-benzyl-3-methyl-8-(piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione
|
106306-87-0
|
C18H21N5O2
|
|
5-[(Benzylsulfonyl)methyl]-1,3,4-thiadiazol-2-amine
|
106307-38-4
|
C10H11N3O2S2
|
|
1,2-Bis(di-2-pyridylphosphino)ethane,min.98%
|
106308-26-3
|
C22H20N4P2
|
|
Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide)
|
106308-41-2
|
C10H9FN4O
|
|
1-(2-FLUORO-BENZYL)-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID
|
106308-42-3
|
C10H8FN3O2
|
|
Rufinamide
|
106308-44-5
|
C10H8F2N4O
|
|
1-(2-CHLORO-6-FLUORO-BENZYL)-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID
|
106308-57-0
|
C10H7ClFN3O2
|
|
6-Amino-8-morpholino-1,7-naphthyridine
|
106309-54-0
|
C12H14N4O
|
|
2,6,10-Dodecatriene-1,12-diol
|
106310-19-4
|
C15H10F3NO2S
|
|
2-(4-TRIFLUOROMETHYLTHIOBENZOXY)-5-NITROTOLUENE
|
106310-21-8
|
C14H10F3NO3S
|
|
4-Methoxy-2-(trifluoromethyl)benzaldehyde
|
106312-36-1
|
C9H7F3O2
|
|
1,25-dihydroxy-21-nor-20-oxavitamin D3
|
106315-28-0
|
C25H40O4
|
|
ETHYL 3-CHLORO-2,2-DIMETHYLPROPANOATE
|
106315-37-1
|
C7H13ClO2
|
|
4-N-DECYLOXY-2-FLUOROBENZOIC ACID
|
106316-02-3
|
C17H25FO3
|
|
1-PIPERIDIN-2-YL-ETHANONE HYDROCHLORIDE
|
106318-66-5
|
C7H14ClNO
|